What is new in 2019 ESC Clinical Practice Guidelines? Guidelines for the diagnosis and treatment of chronic coronary syndromes Review article

Article Sidebar

Requires Subscription PDF (Język Polski)


Published: Dec 31, 2019
DOI: https://doi.org/10.24292/01.MF.0419.8
Keywords:
chronic coronary syndrome, coronary CTA, non-invasive functional imaging for myocardial ischaemia, NOAC, rivaroxaban, ezetimibe

Main Article Content

Aneta Mrozińska
Katedra i Klinika Kardiologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Wydział Lekarski, Warszawski Uniwersytet Medyczny, Mazowiecki Szpital Bródnowski
Anna Sobieszek
Katedra i Klinika Kardiologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Wydział Lekarski, Warszawski Uniwersytet Medyczny, Mazowiecki Szpital Bródnowski
Ewelina Zamecka
Katedra i Klinika Kardiologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Wydział Lekarski, Warszawski Uniwersytet Medyczny, Mazowiecki Szpital Bródnowski
Paulina Ładak
Katedra i Klinika Kardiologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Wydział Lekarski, Warszawski Uniwersytet Medyczny, Mazowiecki Szpital Bródnowski
Marek Kuch
Katedra i Klinika Kardiologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Wydział Lekarski, Warszawski Uniwersytet Medyczny, Mazowiecki Szpital Bródnowski

Abstract

New ESC Guidelines for chronic coronary syndromes modifies recommendations for the diagnosis and treatment this group of patients. The new phrase “Clinical likelihood of CAD” has been introduced and determines appropriate selection of diagnostic method. The latest guidelines emphasizes the role of non-invasive testing, mostly the coronary CTA while significantly reduces the role of exercise ECG. Pharmacotherapy shows the benefits of intensive anticoagulation, increasing the importance of new oral anticoagulants (NOAC), especially low dose rivaroxaban in dual therapy with acetylsalicylic acid. In addition, the role of ezetimibe and new anti-diabetic drugs – SGLT2 inhibitors and GLP-1 antagonists – has been strengthened.

Article Details

How to Cite
Mrozińska, A., Sobieszek, A., Zamecka , E., Ładak, P., & Kuch , M. (2019). What is new in 2019 ESC Clinical Practice Guidelines? Guidelines for the diagnosis and treatment of chronic coronary syndromes. Medycyna Faktow (J EBM), 12(4(45), 354-357. https://doi.org/10.24292/01.MF.0419.8
Issue
Vol 12 No 4(45) (2019)
Section
Articles

Copyright © by Medical Education. All rights reserved.

References

1. Knuuti J., Wijns W., Saraste A. et al.; ESC Scientific Document Group: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 2019; pii: ehz425.
2. Montalescot G., Sechtem U., Achenbach S. et al.: 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013; 34: 2949-3003.